insurance changes to glp-1 drugs glp 1 CMS Issues Coverage Guidance on Anti-Obesity Upcoming Insurance Changes for GLP-1 – Attention members! Exciting changes to – MassHealth and the Group Insurance

Preclinical literature describes Dihexa as a potentiator of the hepatocyte growth factor (HGF) and c-Met receptor system, studied in the context of synaptogenesis in animal models

Event Friday, April 10, 2026 Friday, April 10, 2026, 10 a.m

$380.00 Research Use Only Laboratory-Grade Research Peptide Overview BPC-157 15mg is a premium-grade synthetic pentadecapeptide supplied by Bio-Peptides for precision biochemical and molecular research

Batch: GF-TESAIPA10/3-B242 Tesamorelin Assay: 10.90 mg Ipamorelin Assay: 3.57 mg Tesamorelin Purity: 99.7 percent Ipamorelin Purity: greater than 99.8 percent Tesamorelin Identification by RT: 0.991 Ipamorelin Identification by RT: 0.992 Molecular Ion Mass Identification (Tesamorelin): 5135 Da Molecular Ion Mass Identification (Ipamorelin): 993 Da Bacterial Endotoxins: 0.014 EU/mg Total Aerobic Microbial Count: Not detected Total Yeast and Mold Count: Not detected Research Applications In controlled laboratory environments, Tesamorelin / Ipamorelin may be utilised in experimental models designed to investigate peptide signalling systems and receptor interaction pathways

The Pernicious Anaemia Society and the NIH B12 professional fact sheet are both reliable places to read further